Gastrointestinal Therapeutics Market 2027 By Type, Route of Administration, Application, Distribution Channel and Geography | The Insight Partners

Gastrointestinal Therapeutics Market to 2027 - Global Analysis and Forecasts By Type (Branded and Generics); Route of Administration (Oral, Intravenous, and Others); Application (Ulcerative Colitis, Crohn's Disease, Gastroesophageal Reflux Disease (GERD), and Other Applications); Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and Geography

Report Code: TIPRE00006729 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Gastrointestinal diseases refer to the medical conditions which are related to the digestive tract and the other organs associated during the process of digestion. The gastrointestinal tract consists of organs such as the esophagus, stomach, small & large intestine, and rectum. The accessory organs used while the process of digestion includes liver, gallbladder, and pancreas. Gastrointestinal therapeutics is a branch of medicine that provides treatment for gastrointestinal disease and decides the action of remedial agents.

MARKET DYNAMICS

The gastrointestinal therapeutics market is anticipated to grow in the forecast, owing to the growing cases of gastrointestinal infections along with the increasing aging population. In addition, the rising adoption of unhealthy food eating habits is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Gastrointestinal Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of gastrointestinal therapeutics market with detailed market segmentation by type, route of administration, application, distribution channel, and geography. The global gastrointestinal therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading gastrointestinal therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global gastrointestinal therapeutics market is segmented on the basis of type, route of administration, application, and distribution channel. Based on type, the market is segmented as, branded and generics. The gastrointestinal therapeutics market is categorized based on route of administration such as, oral, intravenous, and others. On the basis of application, the market is segmented as, ulcerative colitis, crohn's disease, gastroesophageal reflux disease (GERD), and other applications. Similarly, based on distribution channel, the gastrointestinal therapeutics market is classified as, Hospital Pharmacies, Retail Pharmacies and Online Pharmacies

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global gastrointestinal therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The gastrointestinal therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting gastrointestinal therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the gastrointestinal therapeutics market in these regions.


MARKET PLAYERS


The report covers key developments in the gastrointestinal therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from gastrointestinal therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for gastrointestinal therapeutics market in the global market. Below mentioned is the list of few companies engaged in the gastrointestinal therapeutics market.

The report also includes the profiles of key gastrointestinal therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Abbott
  •  AbbVie Inc.
  •  ALLERGAN
  •  AstraZeneca
  •  Bayer AG
  •  GlaxoSmithKline plc.
  •  Janssen Global Services, LLC
  •  Pfizer Inc.
  •  Salix Pharmaceuticals
  •  Takeda Pharmaceutical Company Limited
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gastrointestinal Therapeutics Market - By Type
1.3.2 Gastrointestinal Therapeutics Market - By Route of Administration
1.3.3 Gastrointestinal Therapeutics Market - By Application
1.3.4 Gastrointestinal Therapeutics Market - By Distribution Channel
1.3.5 Gastrointestinal Therapeutics Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. GASTROINTESTINAL THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. GASTROINTESTINAL THERAPEUTICS MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. GASTROINTESTINAL THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS

6.1. GASTROINTESTINAL THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. GASTROINTESTINAL THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. GASTROINTESTINAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE

7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BRANDED
7.3.1. Overview
7.3.2. Branded Market Forecast and Analysis
7.3.3. Aminosalicylates Market
7.3.3.1. Overview
7.3.3.2. Aminosalicylates Market Forecast and Analysis
7.3.4. Antacids Market
7.3.4.1. Overview
7.3.4.2. Antacids Market Forecast and Analysis
7.3.5. Enzyme Replacement Therapies Market
7.3.5.1. Overview
7.3.5.2. Enzyme Replacement Therapies Market Forecast and Analysis
7.3.6. Proton Pump Inhibitors Market
7.3.6.1. Overview
7.3.6.2. Proton Pump Inhibitors Market Forecast and Analysis
7.3.7. Laxatives Market
7.3.7.1. Overview
7.3.7.2. Laxatives Market Forecast and Analysis
7.3.8. Antiemetics Market
7.3.8.1. Overview
7.3.8.2. Antiemetics Market Forecast and Analysis
7.3.9. H2 Antagonists Market
7.3.9.1. Overview
7.3.9.2. H2 Antagonists Market Forecast and Analysis
7.3.10. Antidiarrheals Market
7.3.10.1. Overview
7.3.10.2. Antidiarrheals Market Forecast and Analysis
7.3.11. Biologics Market
7.3.11.1. Overview
7.3.11.2. Biologics Market Forecast and Analysis
7.3.12. Others Market
7.3.12.1. Overview
7.3.12.2. Others Market Forecast and Analysis
7.4. GENERICS
7.4.1. Overview
7.4.2. Generics Market Forecast and Analysis

8. GASTROINTESTINAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION

8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INTRAVENOUS
8.4.1. Overview
8.4.2. Intravenous Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis

9. GASTROINTESTINAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION

9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ULCERATIVE COLITIS
9.3.1. Overview
9.3.2. Ulcerative Colitis Market Forecast and Analysis
9.4. CROHN'S DISEASE
9.4.1. Overview
9.4.2. Crohn's Disease Market Forecast and Analysis
9.5. GASTROESOPHAGEAL REFLUX DISEASE (GERD)
9.5.1. Overview
9.5.2. Gastroesophageal Reflux Disease (GERD) Market Forecast and Analysis
9.6. OTHER APPLICATIONS
9.6.1. Overview
9.6.2. Other Applications Market Forecast and Analysis

10. GASTROINTESTINAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL

10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES
10.5.1. Overview
10.5.2. Online Pharmacies Market Forecast and Analysis

11. GASTROINTESTINAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

11.1. NORTH AMERICA
11.1.1 North America Gastrointestinal Therapeutics Market Overview
11.1.2 North America Gastrointestinal Therapeutics Market Forecasts and Analysis
11.1.3 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.1.4 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.1.5 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.1.6 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Gastrointestinal Therapeutics Market
11.1.7.1.1 United States Gastrointestinal Therapeutics Market by Type
11.1.7.1.2 United States Gastrointestinal Therapeutics Market by Route of Administration
11.1.7.1.3 United States Gastrointestinal Therapeutics Market by Application
11.1.7.1.4 United States Gastrointestinal Therapeutics Market by Distribution Channel
11.1.7.2 Canada Gastrointestinal Therapeutics Market
11.1.7.2.1 Canada Gastrointestinal Therapeutics Market by Type
11.1.7.2.2 Canada Gastrointestinal Therapeutics Market by Route of Administration
11.1.7.2.3 Canada Gastrointestinal Therapeutics Market by Application
11.1.7.2.4 Canada Gastrointestinal Therapeutics Market by Distribution Channel
11.1.7.3 Mexico Gastrointestinal Therapeutics Market
11.1.7.3.1 Mexico Gastrointestinal Therapeutics Market by Type
11.1.7.3.2 Mexico Gastrointestinal Therapeutics Market by Route of Administration
11.1.7.3.3 Mexico Gastrointestinal Therapeutics Market by Application
11.1.7.3.4 Mexico Gastrointestinal Therapeutics Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Gastrointestinal Therapeutics Market Overview
11.2.2 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis
11.2.3 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.2.4 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.2.5 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.2.6 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Gastrointestinal Therapeutics Market
11.2.7.1.1 Germany Gastrointestinal Therapeutics Market by Type
11.2.7.1.2 Germany Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.1.3 Germany Gastrointestinal Therapeutics Market by Application
11.2.7.1.4 Germany Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.2 France Gastrointestinal Therapeutics Market
11.2.7.2.1 France Gastrointestinal Therapeutics Market by Type
11.2.7.2.2 France Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.2.3 France Gastrointestinal Therapeutics Market by Application
11.2.7.2.4 France Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.3 Italy Gastrointestinal Therapeutics Market
11.2.7.3.1 Italy Gastrointestinal Therapeutics Market by Type
11.2.7.3.2 Italy Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.3.3 Italy Gastrointestinal Therapeutics Market by Application
11.2.7.3.4 Italy Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.4 Spain Gastrointestinal Therapeutics Market
11.2.7.4.1 Spain Gastrointestinal Therapeutics Market by Type
11.2.7.4.2 Spain Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.4.3 Spain Gastrointestinal Therapeutics Market by Application
11.2.7.4.4 Spain Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.5 United Kingdom Gastrointestinal Therapeutics Market
11.2.7.5.1 United Kingdom Gastrointestinal Therapeutics Market by Type
11.2.7.5.2 United Kingdom Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.5.3 United Kingdom Gastrointestinal Therapeutics Market by Application
11.2.7.5.4 United Kingdom Gastrointestinal Therapeutics Market by Distribution Channel
11.2.7.6 Rest of Europe Gastrointestinal Therapeutics Market
11.2.7.6.1 Rest of Europe Gastrointestinal Therapeutics Market by Type
11.2.7.6.2 Rest of Europe Gastrointestinal Therapeutics Market by Route of Administration
11.2.7.6.3 Rest of Europe Gastrointestinal Therapeutics Market by Application
11.2.7.6.4 Rest of Europe Gastrointestinal Therapeutics Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Gastrointestinal Therapeutics Market Overview
11.3.2 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis
11.3.3 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.3.5 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Gastrointestinal Therapeutics Market
11.3.7.1.1 Australia Gastrointestinal Therapeutics Market by Type
11.3.7.1.2 Australia Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.1.3 Australia Gastrointestinal Therapeutics Market by Application
11.3.7.1.4 Australia Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.2 China Gastrointestinal Therapeutics Market
11.3.7.2.1 China Gastrointestinal Therapeutics Market by Type
11.3.7.2.2 China Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.2.3 China Gastrointestinal Therapeutics Market by Application
11.3.7.2.4 China Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.3 India Gastrointestinal Therapeutics Market
11.3.7.3.1 India Gastrointestinal Therapeutics Market by Type
11.3.7.3.2 India Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.3.3 India Gastrointestinal Therapeutics Market by Application
11.3.7.3.4 India Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.4 Japan Gastrointestinal Therapeutics Market
11.3.7.4.1 Japan Gastrointestinal Therapeutics Market by Type
11.3.7.4.2 Japan Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.4.3 Japan Gastrointestinal Therapeutics Market by Application
11.3.7.4.4 Japan Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.5 South Korea Gastrointestinal Therapeutics Market
11.3.7.5.1 South Korea Gastrointestinal Therapeutics Market by Type
11.3.7.5.2 South Korea Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.5.3 South Korea Gastrointestinal Therapeutics Market by Application
11.3.7.5.4 South Korea Gastrointestinal Therapeutics Market by Distribution Channel
11.3.7.6 Rest of Asia-Pacific Gastrointestinal Therapeutics Market
11.3.7.6.1 Rest of Asia-Pacific Gastrointestinal Therapeutics Market by Type
11.3.7.6.2 Rest of Asia-Pacific Gastrointestinal Therapeutics Market by Route of Administration
11.3.7.6.3 Rest of Asia-Pacific Gastrointestinal Therapeutics Market by Application
11.3.7.6.4 Rest of Asia-Pacific Gastrointestinal Therapeutics Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Gastrointestinal Therapeutics Market Overview
11.4.2 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis
11.4.3 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.4.5 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Gastrointestinal Therapeutics Market
11.4.7.1.1 South Africa Gastrointestinal Therapeutics Market by Type
11.4.7.1.2 South Africa Gastrointestinal Therapeutics Market by Route of Administration
11.4.7.1.3 South Africa Gastrointestinal Therapeutics Market by Application
11.4.7.1.4 South Africa Gastrointestinal Therapeutics Market by Distribution Channel
11.4.7.2 Saudi Arabia Gastrointestinal Therapeutics Market
11.4.7.2.1 Saudi Arabia Gastrointestinal Therapeutics Market by Type
11.4.7.2.2 Saudi Arabia Gastrointestinal Therapeutics Market by Route of Administration
11.4.7.2.3 Saudi Arabia Gastrointestinal Therapeutics Market by Application
11.4.7.2.4 Saudi Arabia Gastrointestinal Therapeutics Market by Distribution Channel
11.4.7.3 U.A.E Gastrointestinal Therapeutics Market
11.4.7.3.1 U.A.E Gastrointestinal Therapeutics Market by Type
11.4.7.3.2 U.A.E Gastrointestinal Therapeutics Market by Route of Administration
11.4.7.3.3 U.A.E Gastrointestinal Therapeutics Market by Application
11.4.7.3.4 U.A.E Gastrointestinal Therapeutics Market by Distribution Channel
11.4.7.4 Rest of Middle East and Africa Gastrointestinal Therapeutics Market
11.4.7.4.1 Rest of Middle East and Africa Gastrointestinal Therapeutics Market by Type
11.4.7.4.2 Rest of Middle East and Africa Gastrointestinal Therapeutics Market by Route of Administration
11.4.7.4.3 Rest of Middle East and Africa Gastrointestinal Therapeutics Market by Application
11.4.7.4.4 Rest of Middle East and Africa Gastrointestinal Therapeutics Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Gastrointestinal Therapeutics Market Overview
11.5.2 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis
11.5.3 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Type
11.5.4 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Route of Administration
11.5.5 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Application
11.5.6 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America Gastrointestinal Therapeutics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Gastrointestinal Therapeutics Market
11.5.7.1.1 Brazil Gastrointestinal Therapeutics Market by Type
11.5.7.1.2 Brazil Gastrointestinal Therapeutics Market by Route of Administration
11.5.7.1.3 Brazil Gastrointestinal Therapeutics Market by Application
11.5.7.1.4 Brazil Gastrointestinal Therapeutics Market by Distribution Channel
11.5.7.2 Argentina Gastrointestinal Therapeutics Market
11.5.7.2.1 Argentina Gastrointestinal Therapeutics Market by Type
11.5.7.2.2 Argentina Gastrointestinal Therapeutics Market by Route of Administration
11.5.7.2.3 Argentina Gastrointestinal Therapeutics Market by Application
11.5.7.2.4 Argentina Gastrointestinal Therapeutics Market by Distribution Channel
11.5.7.3 Rest of South and Central America Gastrointestinal Therapeutics Market
11.5.7.3.1 Rest of South and Central America Gastrointestinal Therapeutics Market by Type
11.5.7.3.2 Rest of South and Central America Gastrointestinal Therapeutics Market by Route of Administration
11.5.7.3.3 Rest of South and Central America Gastrointestinal Therapeutics Market by Application
11.5.7.3.4 Rest of South and Central America Gastrointestinal Therapeutics Market by Distribution Channel

12. INDUSTRY LANDSCAPE

12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. GASTROINTESTINAL THERAPEUTICS MARKET, KEY COMPANY PROFILES

13.1. ABBOTT
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBVIE INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ALLERGAN
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ASTRAZENECA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BAYER AG
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GLAXOSMITHKLINE PLC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JANSSEN GLOBAL SERVICES, LLC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PFIZER INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SALIX PHARMACEUTICALS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TAKEDA PHARMACEUTICAL COMPANY LIMITED
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX

14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. AbbVie Inc.
3. ALLERGAN
4. AstraZeneca
5. Bayer AG
6. GlaxoSmithKline plc.
7. Janssen Global Services, LLC
8. Pfizer Inc.
9. Salix Pharmaceuticals
10. Takeda Pharmaceutical Company Limited